Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
暂无分享,去创建一个
H. Sather | P. Coccia | G. Hammond | M. Waskerwitz | G. Gilchrist | R. O'brien | D. Tubergen | H. Sather | P. Coccia
[1] R. Arriagada,et al. Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Mulhern,et al. A Prospective Comparison of Neuropsychologic Performance of Children Surviving Leukemia Who Received 18-Gy, 24-Gy, or No Cranial Irradiation , 1991 .
[3] R. Gelber,et al. Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Steinherz Pg. Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL. , 1989 .
[5] O. Colvin,et al. Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys. , 1988, Cancer research.
[6] G. Chrousos,et al. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Bleyer Wa,et al. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. , 1985 .
[8] A. Bleyer,et al. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). , 1984, International journal of radiation oncology, biology, physics.
[9] H. Sather,et al. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] P. Dyment,et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study , 1982 .
[11] L. Robison,et al. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group. , 1982, Cancer research.
[12] L. Robison,et al. EFFECT OF ISOLATED CENTRAL NERVOUS SYSTEM LEUKAEMIA ON BONE MARROW REMISSION AND SURVIVAL IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA A Report for Children's Cancer Study Group , 1981, The Lancet.
[13] H. Gadner,et al. Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen* , 1981 .
[14] L. Robison,et al. PRESYMPTOMATIC CENTRAL NERVOUS SYSTEM THERAPY IN PREVIOUSLY UNTREATED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA: COMPARISON OF 1800 RAD AND 2400 RAD A Report for Children's Cancer Study Group , 1981, The Lancet.
[15] J. Chessells,et al. Long-term control of central nervous system leukaemia. , 1977, Archives of disease in childhood.
[16] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[17] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[18] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[19] J. Ochs,et al. Neurotoxicity due to central nervous system therapy for childhood leukemia. , 1989, The American journal of pediatric hematology/oncology.
[20] C. Pui,et al. Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications. , 1988, Blood.
[21] L. Rorke,et al. Long-term sequelae of cancer treatment on the central nervous system in childhood. , 1987, Medical and pediatric oncology.
[22] H. Sather,et al. Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features. , 1987, Haematology and blood transfusion.